USCAP announces with pride a unique interactive microscopy course dedicated to hematopoietic malignancies taught by proverbial giants in the field of neoplastic hematopathology. The morphologic detail and ancillary diagnostic studies required for accurate diagnosis and classification of this constellation of diseases require intense study and understanding of their criteria and differential considerations. Taking this course with these stellar hematopathologists, will sharpen your skills with cutting edge perspective.
- Review diagnostic criteria for Hodgkin and non-Hodgkin lymphoma
- Become familiar with reactive conditions that may mimic hematopoietic conditions in lymph nodes, spleen and marrow
- Review the diagnosis and classification of acute leukemias
- Review the diagnosis and classification of chronic myeloid neoplasms, including myelodysplastic syndromes and myeloproliferative neoplasms
- Review unique proliferations in the spleen
Practicing academic and community
pathologists, pathologists-in-training, hematopathologists
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and
Canadian Academy of Pathology designates this enduring material for a maximum
of 11 AMA PRA Category 1 CreditsTM
. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 11 SAM credit hours.
The faculty, committee members, and staff who are in position
to control the content of this activity are required to disclose to USCAP and
to learners any relevant financial relationship(s) of the individual or
spouse/partner that have occurred within the last 12 months with any commercial
interest(s) whose products or services are related to the CME
content. USCAP has reviewed all disclosures and resolved or managed all
identified conflicts of interest, as applicable.
The following faculty reported no relevant financial
relationships: Daniel A. Arber, M.D., Eric His, M.D., Attillio Orazi, M.D. FRCPath, Kaaren K. Reichard, M.D.
USCAP staff associated with the development of
content for this activity reported no relevant financial relationships.